Scientific Program


 

7:00 – 7:30 a.m.
REGISTRATION AND MORNING COFFEE

 

7:30 – 7:45 a.m.
WELCOME AND OVERVIEW

Jennifer Cook, MD, University of Cincinnati, Cincinnati, OH USA
 

7:45 – 9:05 a.m.
SESSION 1

Chair: Jennifer Cook, MD, University of Cincinnati, Cincinnati, OH USA
 
7:45 a.m. – Introduction to Mechanical Circulatory Support: Current Trends and Outcomes (15 minutes)
Shashank Sinha, MD, MSc, Inova Heart & Vascular Institute, Falls Church, VA USA

Teaching/Discussion Points
  1. Review current trends of temporary and durable MCS utilization
  2. Review clinical outcomes, including survival and adverse events
     
8:00 a.m. – Matching the Right Device to the Right Patient at the Right Time (15 Minutes)
Douglas Horstmanshof, MD, Integris Baptist Medical Center, Oklahoma City, OK USA

Teaching/Discussion Points
  1. Patient selection in durable MCS: indications and contraindications
  2. Lessons learned in timely evaluation
     
8:15 a.m. – Q& A with Panel (10 Minutes)

8:25 a.m. – Surgical Implantation Overview (15 Minutes)
Ezequiel Molina, MD, Piedmont Heart Institute, Atlanta, GA USA

Teaching/Discussion Points
  1. Key aspects of implantation techniques
  2. Assessment of proper VAD positioning
  3. Alternative surgical approaches
     
8:40 a.m. – Valvular Disease and VAD: How Much is Too Much? (15 Minutes)
Ezequiel Molina, MD, Piedmont Heart Institute, Atlanta, GA USA

Teaching/Discussion Points
  1. Management of aortic valve insufficiency
  2. Approach to tricuspid and mitral valve insufficiency
  3. Other concomitant interventions
     
8:55 a.m. – Q&A with Panel (10 Minutes)
 

9:05 – 9:25 a.m.
COFFEE BREAK

 

9:25 – 11:20 a.m.
SESSION 2

Chair: Shashank Sinha, MD, MSc, Inova Heart and Vascular Institute, Falls Church, Virginia
 
9:25 a.m. – Session Overview (20 Minutes)
Shashank Sinha, MD, MSc, Inova Heart and Vascular Institute, Falls Church, VA USA

9:45 a.m. – The Approach to IMACS 1: Short-Term Mechanical Circulatory Support for Cardiogenic Shock (15 minutes)
Manreet Kanwar, MD, Allegheny General Hospital, Pittsburgh, PA USA

Teaching/Discussion Points
  1. Early recognition and phenotyping patients in cardiogenic shock
  2. Decision making for temporary MCS: bridge to transplant, bridge to durable VAD, bridge to recovery or bridge to decision
     
10:00 a.m. – Percutaneous MCS Escalation and De-escalation Strategies for Cardiogenic Shock (15 Minutes)
Jaime Hernandez-Montfort, MD, MPH, MSc Baylor Scott and White Health, Austin, TX USA

Teaching/Discussion Points
  1. Identifying appropriate strategies for escalation in AMI vs ADHF shock
  2. Utilizing congestive hemodynamic profiles to determine optimal short-term MCS device selection
     
10:15 a.m. – Optimal Critical Care Management of the MCS Patient (15 minutes)
Varinder Randhawa, MD, PhD, University of Toronto, Toronto, ON Canada

Teaching/Discussion Points
  1. Recognizing readiness to wean and de-escalation strategies
  2. Complications of percutaneous MCS
     
10:30 a.m. – Assessing and Optimizing RV Function Pre-Operatively (15 minutes)
Ryan Tedford, MD, Medical University of South Carolina, Charleston, SC USA

Teaching/Discussion Points
  1. Non-invasive and Invasive assessment of right ventricular function
  2. Optimization of RV prior to MCS
     
10:45 a.m. – Managing the RV Post-Operatively (15 minutes)
Jonathan Grinstein, MD, University of Chicago, Chicago, IL USA

Teaching/Discussion Points
  1. Assessment of RV failure in postoperative ICU patients
  2. Strategies to manage RV failure postoperatively
     
11:00 a.m. – Q&A with Panel (20 Minutes)
 

11:20 a.m. – 1:20 p.m.
LUNCH BREAK / HANDS ON LEARNING OPPORTUNITY

 

1:20 – 3:15 p.m.
SESSION 3

Chair: Ezequiel Molina, MD, Piedmont Heart Institute, Atlanta, GA USA
 
1:20 p.m. – Session Overview (15 Minutes)
Ezequiel Molina, MD, Piedmont Heart Institute, Atlanta, GA USA

1:35 p.m. – Aortic Insufficiency in LVAD Recipients: Incidence, Screening, and Management (15 Minutes)
Jennifer Cowger, MD, MS, Henry Ford Hospitals, Detroit, MI USA

Teaching/Discussion Points
  1. Identification of AI in MCS patients
  2. Management of AI in MCS patients
     
1:50 p.m. – Arrhythmias and Pacemaker/Defibrillator Therapy in MCS (15 Minutes)
Rebecca Cogswell, MD, University of Minnesota, Minneapolis, MN USA

Teaching/Discussion Points
  1. Assessment of arrhythmia in MCS patients
  2. Management of arrhythmia post MCS
  3. Indications for ICD and CRT-D in MCS patients
     
2:05 p.m. – Interpreting and Troubleshooting Pump Parameters (15 Minutes)
Jennifer Cook, MD, University of Cincinnati, Cincinnati, OH USA

Teaching/Discussion Points
  1. Review of abnormal pump parameters
  2. Techniques for triage of ambulatory alarms
     
2:20 p.m. – Q&A with Panel (15 Minutes)

2:35 p.m. – Pump Speed Optimization: The Role of Imaging, Biomarkers, and Hemodynamics (15 Minutes)
Palak Shah, MD, MS, Inova Heart & Vascular Institute, Falls Church, VA USA

Teaching/Discussion Points
  1. Review of commonly used MCS parameters
  2. Technical aspects of ramp studies
  3. How to prevent readmissions?
     
2:50 p.m. – LVAD Infections: Prevention, Diagnosis, and Management (15 Minutes)
Jennifer Cowger, MD, MS, Henry Ford Hospitals, Detroit, MI USA

Teaching/Discussion Points
  1. Classification of infection in MCS patients
  2. Approach to drive line care and infection management
     
3:05 p.m. – Q&A with Panel (10 minutes)
 

3:15 – 3:30 p.m.
COFFEE BREAK

 

3:30 – 5:35 p.m.
SESSION 4

Chair: Jennifer Cook, MD, University of Cincinnati, Cincinnati, OH USA
 
3:30 p.m. – Session Overview (20 Minutes)
Jennifer Cook, MD, University of Cincinnati, Cincinnati, OH USA

3:50 p.m. – GI Bleeding (15 Minutes)
Jennifer Cook, MD, University of Cincinnati, Cincinnati, OH USA

Teaching/Discussion Points
  1. Assessment of GI bleeding in MCS patients
  2. Management of GI bleeding in MCS patients
     
4:05 p.m. – Antithrombotic Therapy and Thromboembolic Complications of MCS (15 Minutes)
Palak Shah, MD, MS, Inova Heart & Vascular Institute, Falls Church, VA USA

Teaching/Discussion Points
  1. Identification and management of pump thrombosis
  2. Management of stroke in the MCS patient
  3. Anticoagulation strategies and bridging
     
4:20 p.m. – Q&A with Panel (10 Minutes)

4:30 p.m. – Optimal Outpatient Management and Remote Monitoring of VAD Recipients (15 minutes)
Farooq Sheikh, MD, MedStar Heart and Vascular Institute, Washington, DC USA

Teaching/Discussion Points
  1. Overview of essential programmatic infrastructure
  2. Outline of patient assessment in the ambulatory setting
     
4:45 p.m. – The Impact of Frailty on VAD Success (15 Minutes)
Rebecca Cogswell, MD, University of Minnesota, Minneapolis, MN USA

Teaching/Discussion Points
  1. Assessment of frailty in MCS
     
5:00 p.m. – Promoting and Achieving Recovery with MCS (15 Minutes)
Stavros Drakos, MD, PhD, FACC, University of Utah, Salt Lake City, UT USA

Teaching/Discussion Points
  1. Recognize characteristics that portend favorable prognosis for recovery
  2. Protocols and procedures to promote recovery
  3. Recognition of remission vs. recovery
     
5:15 p.m. – Q&A with Panel (10 Minutes)
 

5:25 – 5:35 p.m.
SUMMARY / EVALUATION

Jennifer Cook, MD, University of Cincinnati, Cincinnati, OH USA
 

5:35 p.m.
ADJOURN